Article Details
Retrieved on: 2018-02-05 23:45:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Jan.6, 2018, Baltimore, Maryland- <b>Insilico Medicine</b>, Inc. ("Insilico"), a Baltimore-based next-generation artificial intelligence (AI) company specializing in the application of deep learning for drug discovery, announces that Juvenescence.AI, its joint venture with Juvenescence Limited ("Juvenescence"), ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here